Acquisition Agreement with Boehringer Ingelheim for NBE-Therapeutics Marks First Major Biotech Exit for PPF Group €1.18 billion acquisition provides for significant returns to PPF Group as NBE’s largest shareholder SOTIO, a clinical stage immuno-oncology company, and a member of PPF Group, continues development...